help button home button Am J Pathol Epitomics
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Teitelbaum, S. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Teitelbaum, S. L.
(American Journal of Pathology. 2007;170:427-435.)
© 2007 American Society for Investigative Pathology
DOI: 10.2353/ajpath.2007.060834


Rous-Whipple Award Lecture

Osteoclasts: What Do They Do and How Do They Do It?

Steven L. Teitelbaum

From the Department of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri

Abstract

As Americans live longer, degenerative skeletal diseases, such as osteoporosis, become increasingly prevalent. Regardless of cause, osteoporosis reflects a relative enhancement of osteoclast activity. Thus, this unique bone resorptive cell is a prominent therapeutic target. A number of key observations provide insights into the mechanisms by which precursors commit to the osteoclast phenotype and how the mature cell degrades bone. The osteoclast is a member of the monocyte/macrophage family that differentiates under the aegis of two critical cytokines, namely RANK ligand and M-CSF. Tumor necrosis factor (TNF)-{alpha} also promotes osteoclastogenesis, particularly in states of inflammatory osteolysis such as that attending rheumatoid arthritis. Once differentiated, the osteoclast forms an intimate relationship with the bone surface via the {alpha}vß3 integrin, which transmits matrix-derived, cytoskeleton-organizing, signals. These integrin-transmitted signals include activation of the associated proteins, c-src, syk, Vav3, and Rho GTPases. The organized cytoskeleton generates an isolated microenvironment between the cell’s plasma membrane and the bone surface in which matrix mineral is mobilized by the acidic milieu and organic matrix is degraded by the lysosomal protease, cathepsin K. This review focuses on these and other molecules that mediate osteoclast differentiation or function and thus serve as candidate anti-osteoporosis therapeutic targets.





This article has been cited by other articles:


Home page
GENES CELLSHome page
R. Hazama, X. Qu, K. Yokoyama, C. Tanaka, E. Kinoshita, J. He, S. Takahashi, K. Tohyama, H. Yamamura, and Y. Tohyama
ATP-induced osteoclast function: the formation of sealing-zone like structure and the secretion of lytic granules via microtubule-deacetylation under the control of Syk
Genes Cells, July 1, 2009; 14(7): 871 - 884.
[Abstract] [Full Text] [PDF]


Home page
Anticancer ResHome page
N. KUDO, A. OGOSE, T. ARIIZUMI, H. KAWASHIMA, T. HOTTA, H. HATANO, T. MORITA, M. NAGATA, Y. SIKI, A. KAWAI, et al.
Expression of Bone Morphogenetic Proteins in Giant Cell Tumor of Bone
Anticancer Res, June 1, 2009; 29(6): 2219 - 2225.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Z. Xu, M. A. Hurchla, H. Deng, O. Uluckan, F. Bu, A. Berdy, M. C. Eagleton, E. A. Heller, D. H. Floyd, W. P. Dirksen, et al.
Interferon-{gamma} Targets Cancer Cells and Osteoclasts to Prevent Tumor-associated Bone Loss and Bone Metastases
J. Biol. Chem., February 13, 2009; 284(7): 4658 - 4666.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
E.-J. Chang, J. Ha, H. Huang, H. J. Kim, J. H. Woo, Y. Lee, Z. H. Lee, J. H. Kim, and H.-H. Kim
The JNK-dependent CaMK pathway restrains the reversion of committed cells during osteoclast differentiation
J. Cell Sci., August 1, 2008; 121(15): 2555 - 2564.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. K. Chang, L.-J. Raggatt, K. A. Alexander, J. S. Kuliwaba, N. L. Fazzalari, K. Schroder, E. R. Maylin, V. M. Ripoll, D. A. Hume, and A. R. Pettit
Osteal Tissue Macrophages Are Intercalated throughout Human and Mouse Bone Lining Tissues and Regulate Osteoblast Function In Vitro and In Vivo
J. Immunol., July 15, 2008; 181(2): 1232 - 1244.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
H Tilg, A R Moschen, A Kaser, A Pines, and I Dotan
Gut, inflammation and osteoporosis: basic and clinical concepts
Gut, May 1, 2008; 57(5): 684 - 694.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Bai, R. Kopan, W. Zou, M. J. Hilton, C.-t. Ong, F. Long, F. P. Ross, and S. L. Teitelbaum
NOTCH1 Regulates Osteoclastogenesis Directly in Osteoclast Precursors and Indirectly via Osteoblast Lineage Cells
J. Biol. Chem., March 7, 2008; 283(10): 6509 - 6518.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
C. R. Dass and P. F.M. Choong
Zoledronic acid inhibits osteosarcoma growth in an orthotopic model
Mol. Cancer Ther., December 1, 2007; 6(12): 3263 - 3270.
[Abstract] [Full Text] [PDF]


Home page
IBMS BoneKEyHome page
J. E. Aubin, R. Bouillon, T. A. Guise, and I. R. Reid
Meeting Report from the 17th Scientific Meeting of the International Bone and Mineral Society: June 24-29, 2007 in Montreal, Quebec, Canada
IBMS BoneKEy, November 1, 2007; 4(11): 299 - 313.
[Full Text] [PDF]


Home page
JDRHome page
I. Andrade Jr., T.A. Silva, G.A.B. Silva, A.L. Teixeira, and M.M. Teixeira
The Role of Tumor Necrosis Factor Receptor Type 1 in Orthodontic Tooth Movement
Journal of Dental Research, November 1, 2007; 86(11): 1089 - 1094.
[Abstract] [Full Text] [PDF]


Home page
JBJSHome page
S. A. Rodeo, S. Kawamura, C. B. Ma, X.-h. Deng, P. S. Sussman, P. Hays, and L. Ying
The Effect of Osteoclastic Activity on Tendon-to-Bone Healing: An Experimental Study in Rabbits
J. Bone Joint Surg. Am., October 1, 2007; 89(10): 2250 - 2259.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2007 by the American Society for Investigative Pathology.